SWOG clinical trial number
SWOG-8571
Induction Chemotherapy With High-Dose Cyclophosphamide for Poor Prognosis, Disseminated Breast Cancer, with Radiation Therapy in Complete Responders
Closed
Phase
Published
Abbreviated Title
Induction Chemotherapy With High-Dose Cyclophosphamide for Poor Prognosis, Disseminated Breast Cancer, with Radiation Therapy in Complete Responders
Activated
04/15/1986
Closed
01/01/1988
Publication Information Expand/Collapse
1989
Combination chemotherapy and high-dose cyclophosphamide intensification for poor prognosis breast cancer. A Southwest Oncology Group Study.
1988
Non-alkylator induction and high-dose cyclophosphamide (CTX)consolidation in poor-risk, disseminated breast cancer. A SouthwestOncology Group (SWOG) study.